DMIIR NASDAQ
Drugs Made In America Acquisition II Corp.
1W: -8.1%
1M: -20.1%
3M: -32.5%
YTD: -57.2%
$0.06
-0.00 (-6.55%)
Weekly Expected Move ±35.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$4.2M
52W Range0.0503-0.17
Volume24,008
Avg Volume15,252
Beta2.05
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORoger Bendelac
Employees2
SectorFinancial Services
IndustryFinancial - Conglomerates
IPO Date2025-12-04
Websitedmaacorp.com/
420 Lexington Avenue
New York, NY 10170
US
New York, NY 10170
US
954 870 3099
About Drugs Made In America Acquisition II Corp.
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on August 23, 2024 and is headquartered in Fort Lauderdale, FL.
Latest News
No recent news
Recent Insider Trades
No insider trades found